Innovation
2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 37 times.
| Year | Filings |
|---|---|
| 2017 | 2 |
| 2020 | 2 |
| 2023 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developer of active cancer immunotherapy products focused on personalized cancer vaccines
2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 37 times.
| Year | Filings |
|---|---|
| 2017 | 2 |
| 2020 | 2 |
| 2023 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |